Kimia Biosciences Limited (BOM:530313)
30.26
+0.11 (0.36%)
At close: Mar 6, 2026
Kimia Biosciences Revenue
Kimia Biosciences had revenue of 301.01M INR in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to 1.26B, up 13.47% year-over-year. In the fiscal year ending March 31, 2025, Kimia Biosciences had annual revenue of 1.19B with 13.39% growth.
Revenue (ttm)
1.26B
Revenue Growth
+13.47%
P/S Ratio
1.14
Revenue / Employee
5.04M
Employees
250
Market Cap
1.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.19B | 140.44M | 13.39% |
| Mar 31, 2024 | 1.05B | -236.40M | -18.39% |
| Mar 31, 2023 | 1.29B | 36.15M | 2.89% |
| Mar 31, 2022 | 1.25B | -78.13M | -5.89% |
| Mar 31, 2021 | 1.33B | 264.28M | 24.86% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 3.91B |
| Influx Healthtech | 1.24B |
| Smruthi Organics | 1.11B |
| Panchsheel Organics | 1.03B |
| Resonance Specialties | 899.72M |
| Tyche Industries | 505.54M |
| Vasundhara Rasayans | 315.86M |
| Auro Laboratories | 284.46M |